UBS Cuts Mobileye Below Insider Buy Prices
UBS cut its Mobileye price target to $7.50 on October 7, dropping it below the $7.98–$8.46 prices two independent directors paid in July and August. The stock has fallen to $7.10 despite four consecut
UBS Cuts Mobileye Target Below Insider Buy Prices
NEW YORK, October 11 —
UBS cut its Mobileye Global Inc. (MBLY) price target to $7.50 from $9 on October 7, dropping it below the prices two independent directors paid in open-market purchases months earlier. The stock has since slipped to $7.10, below even the reduced analyst target. Four consecutive earnings beats have not closed the gap between insider conviction and market skepticism.
- Directors Yeboah-amankwah and Yeary paid $7.98, $8.46 for ~$199K combined in open-market purchases; both are now underwater at $7.10.
- Mobileye beat adjusted EPS estimates four consecutive quarters, most recently by 226% ($0.19 vs. estimate).
- Short interest at 22.6% of float; mean analyst target of $11.36 sits 60% above current price, but UBS targets $7.50.
Buying Into a Narrative the Market No Longer Prices
Directors Frank D. Yeary and Safroadu Yeboah-amankwah each put roughly $99,000 of personal capital into Mobileye stock: Yeary at $7.98 on July 30, Yeboah-amankwah at $8.46 on August 6. Together, $198,808 deployed at prices now 10-16% above where the stock trades. Their purchases coincided with a moment when Mobileye's valuation story still centered on a full-stack autonomous product arc: from the EyeQ chip powering collision warnings on mass-market cars through Mobileye Drive, the company's no-driver robotaxi platform. UBS's October 7 target cut to $7.50 undercuts both entry points, signaling that analyst doubt has hardened around whether the robotaxi end of that stack ever reaches commercial scale.
The Beats That Haven't Moved the Stock
The adjusted earnings picture looks defensible: four consecutive estimate beats, most recently by 226%, backed by $654 million in trailing free cash flow, a figure worth pressure-testing via a DCF calculator under various growth assumptions, and a $1.44 billion net-cash balance sheet. Gross margin sits at 47.4%; the forward P/E is 14.5x. GAAP trailing EPS of -$4.97 reflects non-cash charges the market refuses to discount in a near-zero-growth environment. Revenue of $2.02 billion grew just 0.4% year over year, leaving the multiple dependent on whether autonomous commercialization ever delivers scale.
| Ticker | Mkt cap | Fwd P/E | 52-wk |
|---|---|---|---|
| MBLY | $6.0B | 14.6x | -53.3% |
| AMBA | $3.0B | 60.2x | -16.7% |
| SYM | $25.8B | 55.2x | -39.5% |
| PATH | $7.0B | 14.6x | -21.4% |
| AUR | $11.7B | n/a | +8.6% |
| GTLB | $9.2B | 53.1x | +24.7% |
What the Next Quarter Has to Show
Short interest at 22.6% of float is a ceiling on price recovery without a catalyst. Four officer-change 8-Ks filed within 120 days, per SEC filings from September, August, and July, add a team-stability question that earnings beats alone cannot answer. The figure to watch is top-line growth: trailing revenue at 0.4% cannot sustain an autonomous-platform multiple without acceleration. Against a mean analyst target of $11.36 and a net-cash balance sheet, the directors' purchases may prove well-timed; the next two to three quarters of revenue will indicate whether that conviction was premature. Run the free Mobileye Global Inc. deep-dive →
Basis Report is independent research for informational purposes. It is not investment advice and not a recommendation to buy or sell any security.
Frequently Asked Questions
What is Mobileye's new stock price target?
UBS cut its Mobileye price target to $7.50 on October 7, down from $9. The stock has since fallen further to $7.10, below even the reduced analyst target.
When did Mobileye insiders buy stock?
Directors Frank D. Yeary and Safroadu Yeboah-amankwah each invested roughly $99,000 in open-market purchases, with Yeary buying at $7.98 on July 30 and Yeboah-amankwah at $8.46 on August 6. Both directors are now underwater at the current stock price of $7.10.
Has Mobileye beaten earnings estimates?
Mobileye has beaten adjusted EPS estimates four consecutive quarters, most recently by 226% on a result of $0.19 versus a $0.058 estimate. However, these earnings beats have failed to drive stock price appreciation.
Why did UBS cut its Mobileye price target?
UBS's downgrade reflects hardened doubt about whether Mobileye's robotaxi platform will ever reach commercial scale. Revenue growth of just 0.4% year over year leaves the stock dependent on autonomous commercialization for valuation support.
What is Mobileye's financial position?
Mobileye maintains a $1.44 billion net-cash balance sheet and $654 million in trailing free cash flow. The company has a 47.4% gross margin and trades at 14.5x forward P/E, though GAAP trailing EPS stands at -$4.97 due to non-cash charges.
UBS cut its Mobileye price target to $7.50 from $9 this week, citing skepticism about the company's autonomous-driving ambitions — dropping the revised target below the prices at which two independent directors made open-market purchases just months earlier. The stock now trades at $7.10, below both the reduced analyst target and the directors' own cost basis.